Outcomes4Me is a 2024 Fast Company World Changing Idea! Learn more >>

2023 Pre-ASCO Symposium: watch the highlights

Pictured from left to right: Dr. Maya Said, Founder and CEO, Outcomes4Me (moderator) Dr. Prasanth Reddy, SVP, Global Enterprise Oncology Head, Labcorp Suzanne Garner, Stage II breast cancer survivor & NATALEE trial participant Dr. Steven Isakoff, Associate Director, MGH Cancer Research Dr. Kyle Holen, SVP Head of Development, Therapeutics and Oncology, Moderna

We were honored to host an in-person, pre-ASCO Symposium “The Future of AI and Personalized Cancer Care:
How can patient empowerment accelerate improved cancer outcomes?” where we brought together patients, practitioners, and experts in life sciences, digital health, policy, and advocacy to delve into the transformative power of generative AI in the delivery of cancer care. The event featured a keynote opening by Dr. Sunil Verma, SVP, Global Head of Oncology, Medical, AstraZeneca and three panel discussions:

Panel 1: AI in support of delivering patient-centric, guideline-concordant cancer care

In the age of AI, oncologists now have an opportunity to leverage patient-reported outcomes and real-world data to drive guideline-concordant care. This panel explored AI’s role in supporting physician decision-making and its ability to, in turn, better serve patients.

Featuring:

  • Dr. Crystal Denlinger, Chief Scientific Officer, NCCN®
  • Dr. V.K. Gadi, Deputy Director, University of Illinois Cancer Center
  • Dr. Aradhana Ghosh, VP, Oncology Informatics, Labcorp Oncology
  • Dr. Chadi Nabhan, SVP and Chairman, Caris Precision Oncology Alliance
  • Kimberly Richardson, President, Black Cancer Collaborative, patient advocate & cancer survivor
  • Dr. Maya Said, Founder and CEO, Outcomes4Me (moderator)

Panel 2: The role of AI in advancing equitable clinical trial recruitment and access

Our panel of experts and patient advocates discussed the role of AI & digital health solutions in equitable clinical trial recruitment and examine how AI-driven patient empowerment and self-advocacy can contribute to clinical-trial matching.

Featuring:

  • Suzanne Garner, Stage II breast cancer survivor & NATALEE trial participant
  • Dr. Kyle Holen, SVP Head of Development, Therapeutics and Oncology, Moderna
  • Dr. Steven Isakoff, Associate Director, MGH Cancer Research
  • Dr. Prasanth Reddy, SVP, Global Enterprise Oncology Head, Labcorp
  • Dr. Maya Said, Founder and CEO, Outcomes4Me (moderator)

Panel 3: The value of AI-powered, direct-to-patient activation in the consumer privacy era

Our panelists explored how opt-in AI can empower patients with personalized, relevant information, and how this approach coupled with true patient ownership of their medical records will both support the pharmaceutical industry’s commercial goals but also better serve patients.

Featuring:

  • Dr. Grace Cordovano, BCPA, Founder, Enlightening Results
  • Dr. Debra Friedman, Associate Director, Community Science & Health Outcomes, Vanderbilt Ingram Cancer Center
  • Dr. Arun Krishna, VP Head of US Lung Cancer business, AstraZeneca
  • Susan Manber, Chief Patient Officer at Publicis Health
  • Brenna Fitzgerald, VP of Marketing & Communications, Outcomes4Me (moderator)

We’re excited to share the video highlights from the event, along with the full panels. Please watch and share with others in your network who might enjoy this rich discussion!

WATCH FULL PANELS

Related Articles

Preparing for a hospital stay, especially for an extended period, is essential for ensuring comfort...
The life expectancy for stage 4 non-small cell lung cancer (NSCLC) without treatment can vary...